SPOTLIGHT: FDA reinstitutes Woodcock as CDER chief


The FDA is handing back the reins to the FDA's Center for Drug Evaluation and Research to Janet Woodcock, who had formerly headed the division for 10 years. The FDA described it as a "lateral move" for Woodcock, who will hang up her title as Deputy Commissioner for scientific and medical programs. CDER is a key part of the FDA. Its researchers are charged with evaluating the safety and efficacy of drugs, a role that has achieved heightened significance following a string of controversies over therapeutics that contained hidden threats. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.